ALS Patients May Benefit Most from Tailored Brain–Computer Interface Programs

Cognitive impairment may present an obstacle for patients with amyotrophic lateral sclerosis (ALS) using brain-computer interface devices, according to a study published in the Journal of Neural Engineering. The findings underscore the importance of considering disease heterogeneity when designing these potentially beneficial devices for clinical use. The study, “Performance…

In this video by Tim Noonan, we enter the world of Scott Sullivan, an ordinary man showing extraordinary courage. This 39-year-old Queensland dad is battling motor neurone disease and lives every day as if it’s his last. Every minute, every second with his wife and two children is precious because…

In this video by David Steenblock, watch him talk about how he believes is it possible to treat ALS with some tips. Learn more about ALS here: https://bit.ly/ALSNewsToday ALS News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis…

Researchers have, for the first time, managed to selectively alter gene expression in brain motor neurons of mice modeling amyotrophic lateral sclerosis (ALS) without affecting other neurons in the motor cortex. The results are a major step forward in efforts to develop gene replacement therapy for ALS. “The brain is…

In 2013, two men diagnosed with MND set out on an epic adventure. On a customized recumbent tandem bike, the two men rode 1,000,000 meters (1000km) from Brisbane to Sydney to raise awareness for MND, and funds to find a cure. One pedalled with his arms, the other with…

Last week’s hot topic on ALS was the ALS Stem Cell Therapy that Showed Safety and Efficacy in Early Clinical Trials written by Magdalena Kegel.  The article refers to new and potentially promising results from its clinical investigations of NSI-566 — human spinal cord  derived neural stem cells for the treatment of conditions…

Oregon State University researchers were able to stop the progression of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) for nearly two years in a specific type of mouse model. The treatment allowed the animals to live for 650 days – 500 days longer than any other previous treatment has managed.

Stephen Hawking is an English theoretical physicist, cosmologist, author and Director of Research at the Centre for Theoretical Cosmology within the University of Cambridge. He is also well-known for suffering from ALS – amyotrophic lateral sclerosis, a progressive neuro-degenerative disease which affects nerve cells in the brain and the spinal cord. ALS…

“My name is Anthony Carbajal, and I have ALS, also known as Lou Gehrig’s disease and MND.  Let’s fight together!” Learn more about ALS here: https://bit.ly/ALSNewsToday…

Biopharmaceutical company Neuralstem presented new and potentially promising results from its clinical investigations of NSI-566 — human spinal cord-derived neural stem cells for the treatment of conditions including amyotrophic lateral sclerosis (ALS) — at the recent Phacilitate Cell & Gene Therapy World conference in Washington, D.C. Karl Johe, the company’s chairman and chief scientific officer, reported that two clinical trials…